These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 1722374)

  • 1. Basophil histamine release in atopic patients after in vitro provocation with thiopental, Diprivan and chlormethiazole.
    Laxenaire MC; Mata E; Guéant JL; Moneret-Vautrin DA; Haberer JP
    Acta Anaesthesiol Scand; 1991 Nov; 35(8):706-10. PubMed ID: 1722374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The amount of histamine released in vivo by hypnotics (thiopental, methohexital, propofol) studied by assays of plasma histamine].
    Widmer S; Laxenaire MC; Manel J; Gueant JL
    Allerg Immunol (Paris); 1988 Nov; 20(9):346-7. PubMed ID: 2462890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Basophil histamine release studies in the evaluation of a new anaesthetic agent.
    Withington DE
    Agents Actions; 1988 Apr; 23(3-4):337-8. PubMed ID: 2456002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neutrophil attractant/activation protein-1 (NAP-1) causes human basophil histamine release.
    White MV; Yoshimura T; Hook W; Kaliner MA; Leonard EJ
    Immunol Lett; 1989 Aug; 22(2):151-4. PubMed ID: 2476383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the anaesthetic and haemodynamic effects of chlormethiazole and thiopentone.
    Christensen JH; Andreasen F; Kristoffersen MB
    Br J Anaesth; 1983 May; 55(5):391-7. PubMed ID: 6849724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monocyte chemotactic and activating factor is a potent histamine-releasing factor for basophils.
    Alam R; Lett-Brown MA; Forsythe PA; Anderson-Walters DJ; Kenamore C; Kormos C; Grant JA
    J Clin Invest; 1992 Mar; 89(3):723-8. PubMed ID: 1371775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histamine release from basophil leukocytes in asthma patients after in vitro provocation with various neuromuscular blocking drugs and intravenous anaesthetic agents.
    Guldager H; Søndergaard I
    Acta Anaesthesiol Scand; 1987 Nov; 31(8):728-9. PubMed ID: 2449027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Basophil releasability in patients with hymenoptera venom allergy.
    Radermecker MF; Leclercq MD; Mariz SD; Louis RE
    Int Arch Allergy Immunol; 1993; 101(3):283-7. PubMed ID: 7686798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective activity of propofol, Diprivan and intralipid against active oxygen species.
    Mathy-Hartert M; Deby-Dupont G; Hans P; Deby C; Lamy M
    Mediators Inflamm; 1998; 7(5):327-33. PubMed ID: 9883967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [In vivo blood histamine during anesthesia].
    Doenicke A; Lorenz W
    Ann Anesthesiol Fr; 1976; 17(2):219-24. PubMed ID: 62535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased release of histamine in patients with respiratory symptoms related to perfume.
    Elberling J; Skov PS; Mosbech H; Holst H; Dirksen A; Johansen JD
    Clin Exp Allergy; 2007 Nov; 37(11):1676-80. PubMed ID: 17877753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An improved method for the determination of histamine release in man: its application in studies with propanidid and thiopentone.
    Lorenz W; Doenicke A; Meyer R; Reimann HJ; Kusche J; Barth H; Geesing H; Hutzel M; Weissenbacher B
    Eur J Pharmacol; 1972 Aug; 19(2):180-90. PubMed ID: 4116093
    [No Abstract]   [Full Text] [Related]  

  • 13. Enhancement of human basophil histamine release by interleukin 5.
    Hirai K; Yamaguchi M; Misaki Y; Takaishi T; Ohta K; Morita Y; Ito K; Miyamoto T
    J Exp Med; 1990 Nov; 172(5):1525-8. PubMed ID: 1700056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study of IgE-dependent basophil releasability in allergic patients.
    Sanz ML; Latasa M; García BE; Gato JJ; Oehling A
    J Investig Allergol Clin Immunol; 1991 Oct; 1(5):293-301. PubMed ID: 1727011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Non-specific histamine liberation and propofol].
    Laxenaire MC; Khamel L; Heravi Z; Manel J; Bois JP
    Ann Fr Anesth Reanim; 1987; 6(4):230-2. PubMed ID: 2443045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of basophil activation by histamine: a sensitive and reproducible model for the study of the biological activity of high dilutions.
    Sainte-Laudy J; Belon P
    Homeopathy; 2009 Oct; 98(4):186-97. PubMed ID: 19945674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Basophil mediator release in atopic dermatitis.
    Bull HA; Courtney PF; Bunker CB; Rustin MH; Pearce FL; Dowd PM
    J Invest Dermatol; 1993 Mar; 100(3):305-9. PubMed ID: 7680056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Basophilic histamine content and release during venom immunotherapy: insights by flow cytometry.
    Nullens S; Sabato V; Faber M; Leysen J; Bridts CH; De Clerck LS; Falcone FH; Maurer M; Ebo DG
    Cytometry B Clin Cytom; 2013 May; 84(3):173-8. PubMed ID: 23450838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Applying surface plasmon resonance to monitor the IgE-mediated activation of human basophils.
    Suzuki H; Yanase Y; Tsutsui T; Ishii K; Hiragun T; Hide M
    Allergol Int; 2008 Dec; 57(4):347-58. PubMed ID: 18797180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histamine release in man by propanidid and thiopentone: pharmacological effects and clinical consequences.
    Lorenz W; Doenicke A; Meyer R; Reimann HJ; Kusche J; Barth H; Geesing H; Hutzel M; Weissenbacher B
    Br J Anaesth; 1972 Apr; 44(4):355-69. PubMed ID: 4113349
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.